PharmaCyte Biotech Correlations

PMCB Stock

USD 0.65 0.02 3.17%

The current 90-days correlation between PharmaCyte Biotech and Alaunos Therapeutics is 0.03 (i.e., Significant diversification). The correlation of PharmaCyte Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

PharmaCyte Biotech Correlation With Market

Average diversification

The correlation between PharmaCyte Biotech and DJI is 0.19 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PharmaCyte Biotech and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with PharmaCyte Stock

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PharmaCyte Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.

For information on how to trade PharmaCyte Stock refer to our How to Trade PharmaCyte Stock guide.

Moving together with PharmaCyte Stock

0.76	PANACEABIO	Panacea Biotec	Pair Corr
0.63	DRMA	Dermata Therapeutics	Pair Corr
0.66	VINC	Vincerx Pharma, Common	Pair Corr
0.76	VRAX	Virax Biolabs Group	Pair Corr

Moving against PharmaCyte Stock

0.73	DVAX	Dynavax Technologies	Pair Corr
0.62	VCEL	Vericel Corp Ord	Pair Corr
0.58	DSGN	Design Therapeutics	Pair Corr
0.57	VCYT	Veracyte	Pair Corr
0.55	DNLI	Denali Therapeutics	Pair Corr
0.43	VKTX	Viking Therapeutics Sell-off Trend	Pair Corr
0.35	JUMP	Leveljump Healthcare Corp	Pair Corr
0.77	EFTR	Effector Therapeutics	Pair Corr
0.72	VRDN	Viridian Therapeutics	Pair Corr
0.67	VTVT	vTv Therapeutics Downward Rally	Pair Corr
0.49	VTGN	VistaGen Therapeutics	Pair Corr
0.47	VRTX	Vertex Pharmaceuticals	Pair Corr
0.44	ENTA	Enanta Pharmaceuticals Earnings Call This Week	Pair Corr
0.41	ENTX	Entera Bio	Pair Corr

Related Correlations Analysis

	RADX	QNRX	NBY	TCRT	VIVS	IBO	KTTA	PLRZ	CYCN	BCLI
RADX		-0.24	0.19	0.07	0.63	0.72	0.36	0.75	0.66	0.33	RADX
QNRX	-0.24		-0.33	0.8	-0.36	-0.65	-0.53	-0.45	-0.62	-0.53	QNRX
NBY	0.19	-0.33		-0.2	0.41	0.44	0.37	0.26	0.28	0.59	NBY
TCRT	0.07	0.8	-0.2		-0.02	-0.36	-0.37	-0.19	-0.41	-0.38	TCRT
VIVS	0.63	-0.36	0.41	-0.02		0.74	0.23	0.47	0.5	0.31	VIVS
IBO	0.72	-0.65	0.44	-0.36	0.74		0.5	0.8	0.83	0.59	IBO
KTTA	0.36	-0.53	0.37	-0.37	0.23	0.5		0.65	0.46	0.5	KTTA
PLRZ	0.75	-0.45	0.26	-0.19	0.47	0.8	0.65		0.76	0.51	PLRZ
CYCN	0.66	-0.62	0.28	-0.41	0.5	0.83	0.46	0.76		0.6	CYCN
BCLI	0.33	-0.53	0.59	-0.38	0.31	0.59	0.5	0.51	0.6		BCLI
	RADX	QNRX	NBY	TCRT	VIVS	IBO	KTTA	PLRZ	CYCN	BCLI

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CYCN	+ 0.83	IBO
TCRT	+ 0.8	QNRX
PLRZ	+ 0.8	IBO
CYCN	+ 0.76	PLRZ
PLRZ	+ 0.75	RADX
IBO	+ 0.74	VIVS

High negative correlations

IBO	- 0.65	QNRX
CYCN	- 0.62	QNRX
BCLI	- 0.53	QNRX
KTTA	- 0.53	QNRX
PLRZ	- 0.45	QNRX
CYCN	- 0.41	TCRT

Risk-Adjusted Indicators

There is a big difference between PharmaCyte Stock performing well and PharmaCyte Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PharmaCyte Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RADX	3.62	(0.24)	0.00	(0.32)	0.00	0.00	7.44	(7.22)	34.19
QNRX	8.25	3.06	0.30	(0.28)	6.79	(10.43)	12.00	(11.19)	178.74
NBY	9.59	1.23	0.12	1.03	9.62	(11.79)	25.00	(17.95)	100.82
TCRT	5.18	0.95	0.14	(0.37)	5.46	(6.20)	12.10	(10.06)	36.12
VIVS	6.56	0.44	0.07	0.33	6.85	(7.98)	14.55	(10.36)	50.15
IBO	2.41	(0.34)	0.00	(1.15)	0.00	0.00	4.92	(6.25)	19.10
KTTA	3.95	(1.11)	0.00	19.09	0.00	0.00	7.14	(9.59)	43.94
PLRZ	3.60	(0.75)	0.00	(0.22)	0.00	0.00	8.47	(8.11)	38.16
CYCN	4.36	(0.59)	0.00	(0.38)	0.00	0.00	8.24	(10.56)	43.73
BCLI	2.83	0.06	0.01	0.13	3.14	(3.56)	6.06	(5.13)	20.30

PharmaCyte Biotech Corporate Management

CPA CPA	Chief Officer	Profile
HansPeter Hammes	Member Consultant	Profile
Jose MD	Consulting Officer	Profile
HansPeter MD	Member Consultant	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC